CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 90 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,198 | +53.1% | 37,280 | +36.2% | 0.00% | 0.0% |
| Q2 2023 | $116,365 | -19.0% | 27,380 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $143,747 | -13.7% | 27,071 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $166,615 | -40.7% | 26,531 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $281,000 | +105.1% | 26,628 | +5.4% | 0.00% | +100.0% |
| Q2 2022 | $137,000 | -40.9% | 25,274 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $232,000 | +42.3% | 25,253 | +134.3% | 0.00% | 0.0% |
| Q4 2021 | $163,000 | -35.1% | 10,776 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $251,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $11,316,000 | 14.13% |
| Memorial Sloan Kettering Cancer Center | 674,196 | $16,093,000 | 10.03% |
| PFM Health Sciences, LP | 4,092,309 | $88,176,000 | 2.59% |
| CloudAlpha Capital Management Limited/Hong Kong | 305,000 | $7,280,000 | 2.15% |
| Monashee Investment Management LLC | 449,377 | $10,727,000 | 1.98% |
| Avidity Partners Management LP | 2,474,067 | $59,056,000 | 1.31% |
| Green Alpha Advisors, LLC | 32,836 | $784,000 | 0.54% |
| Tekla Capital Management LLC | 699,377 | $15,621,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $4,774,000 | 0.40% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 | $70,738,000 | 0.33% |